These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27938505)
1. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP. Chen Y; Zhang S; Zhao R; Zhao Q; Zhang T Oncol Res; 2017 Sep; 25(8):1215-1222. PubMed ID: 27938505 [TBL] [Abstract][Full Text] [Related]
2. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2. Jiang M; Shi X; Zhu H; Wei W; Li J Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226 [TBL] [Abstract][Full Text] [Related]
3. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling. Zheng X; Rui S; Wang XF; Zou XH; Gong YP; Li ZH J Exp Clin Cancer Res; 2021 May; 40(1):157. PubMed ID: 33962657 [TBL] [Abstract][Full Text] [Related]
4. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit. Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586 [TBL] [Abstract][Full Text] [Related]
5. Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. Gundara JS; Zhao J; Gill AJ; Lee JC; Delbridge L; Robinson BG; McLean C; Serpell J; Sidhu SB Cancer Med; 2015 Feb; 4(2):174-82. PubMed ID: 25487826 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib. Lassalle S; Zangari J; Popa A; Ilie M; Hofman V; Long E; Patey M; Tissier F; Belléannée G; Trouette H; Catargi B; Peyrottes I; Sadoul JL; Bordone O; Bonnetaud C; Butori C; Bozec A; Guevara N; Santini J; Hénaoui IS; Lemaire G; Blanck O; Vielh P; Barbry P; Mari B; Brest P; Hofman P Oncotarget; 2016 May; 7(21):30461-78. PubMed ID: 27036030 [TBL] [Abstract][Full Text] [Related]
8. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma. Sun Y; Zhang L; Zhang S Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Pishkari S; Hadavi R; Koochaki A; Razaviyan J; Paryan M; Hashemi M; Mohammadi-Yeganeh S Horm Mol Biol Clin Investig; 2021 Mar; 42(3):265-271. PubMed ID: 33769725 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC. Shabani N; Razaviyan J; Paryan M; Tavangar SM; Azizi F; Mohammadi-Yeganeh S; Hedayati M Hum Pathol; 2018 Sep; 79():212-221. PubMed ID: 29885402 [TBL] [Abstract][Full Text] [Related]
11. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281 [TBL] [Abstract][Full Text] [Related]
12. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037 [TBL] [Abstract][Full Text] [Related]
13. Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells. Xiong H; Yu J; Jia G; Su Y; Zhang J; Xu Q; Sun X Hum Cell; 2021 Nov; 34(6):1866-1877. PubMed ID: 34346032 [TBL] [Abstract][Full Text] [Related]
14. microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer. Carvalheira G; Nozima BH; Cerutti JM Oncotarget; 2015 Sep; 6(29):28357-70. PubMed ID: 26317551 [TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis. Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875 [TBL] [Abstract][Full Text] [Related]
16. miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8. Liu T; Meng J; Zhang Y Mol Med Rep; 2020 Oct; 22(4):3316-3326. PubMed ID: 32945439 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257 [TBL] [Abstract][Full Text] [Related]
18. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Santarpia L; Calin GA; Adam L; Ye L; Fusco A; Giunti S; Thaller C; Paladini L; Zhang X; Jimenez C; Trimarchi F; El-Naggar AK; Gagel RF Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332 [TBL] [Abstract][Full Text] [Related]
19. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Starenki D; Hong SK; Lloyd RV; Park JI Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367 [TBL] [Abstract][Full Text] [Related]
20. MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2. Chen X; Qi M; Yang Q; Li JY Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):232-240. PubMed ID: 30657565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]